Mutita Junking

Inhibition of IL-10 and TGF-β receptors on dendritic cells enhances activation of effector T-cells to kill cholangiocarcinoma cells

Chutamas Thepmalee, Aussara Panya, Mutita Junking et al. · Human Vaccines & Immunotherapeutics · 2018 · 90 citations · Full text

Anti-mucin 1 chimeric antigen receptor T cells for adoptive T cell therapy of cholangiocarcinoma

Kamonlapat Supimon, Thanich Sangsuwannukul, Jatuporn Sujjitjoon et al. · Scientific Reports · 2021 · 59 citations · Full text

Current Treatments, Immunology, Immune Regulation +23

Fourth-generation chimeric antigen receptor T cells targeting folate receptor alpha antigen expressed on breast cancer cells for adoptive T cell therapy

Piriya Luangwattananun, Mutita Junking, Jatuporn Sujjitjoon et al. · Breast Cancer Research and Treatment · 2021 · 50 citations

Cancer Immunosurveillance, Breast Cancer Cells, Immunology +9

Anti-tumour effect of the fourth-generation chimeric antigen receptor T cells targeting CD133 against cholangiocarcinoma cells

Thanich Sangsuwannukul, Kamonlapat Supimon, Jatuporn Sujjitjoon et al. · International Immunopharmacology · 2020 · 46 citations

Tumor Immunology, Cholangiocarcinoma Cells, Cancer Immunosurveillance +8

Enhancement of PD-L1-attenuated CAR-T cell function through breast cancer-associated fibroblasts-derived IL-6 signaling via STAT3/AKT pathways

Nisa Chuangchot, Pranisa Jamjuntra, Supaporn Yangngam et al. · Breast Cancer Research · 2023 · 46 citations · Full text